BRITAIN'S Medicines and Healthcare products Regulatory Agency (MHRA) has opened a public consultation after recommending that sildenafil be made available over-the-counter as a pharmacist-only medicine.
The recommendation follows a submission by Pfizer to make the product more easily accessible, with the MHRA proposing that 50mg sildenafil citrate tablets should be available for purchase in pharmacy without a script.
Pfizer has produced collateral for pharmacists to use when supplying the product, saying it should not be sold to men with diagnosed cardiovascular conditions.
Feedback is sought by 18 Apr.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Mar 17
